Effect of testosterone and a nutritional supplement, alone and in combination, on hospital admissions in undernourished older men and women

American Journal of Clinical Nutrition

Volumn 89, Issue 3, 2009, Pages 880-889

  Chapman, Ian M ^a   Visvanathan, Renuka ^a   Hammond, Angela J ^a   Morley, John E ^b   Field, John B F ^a   Tai, Kamilia ^a   Belobrajdic, Damien P ^a   Chen, Richard Y T ^a   Horowitz, Michael ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b SAINT LOUIS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; PLACEBO; PROSTATE SPECIFIC ANTIGEN; TESTOSTERONE; TESTOSTERONE UNDECANOATE;

AGED; ARTICLE; BODY COMPOSITION; BODY FAT; BODY MASS; BODY WEIGHT; CALORIC INTAKE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG WITHDRAWAL; FALLING; FEMALE; FRAIL ELDERLY; GERIATRIC NUTRITION; HEMATOCRIT; HIRSUTISM; HOSPITAL ADMISSION; HUMAN; MALE; MALNUTRITION; MORTALITY; MUSCLE STRENGTH; NAUSEA; NUTRITIONAL ASSESSMENT; PATIENT COMPLIANCE; PROSTATE; PROTEIN BLOOD LEVEL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SHORT FORM 36; SIDE EFFECT; TESTOSTERONE BLOOD LEVEL; WALKING; WEIGHT REDUCTION;

AGE FACTORS; AGED; BLOOD GLUCOSE; C-REACTIVE PROTEIN; DIETARY SUPPLEMENTS; ELECTROLYTES; FEMALE; HEMATOCRIT; HOSPITALIZATION; HUMANS; MALE; MALNUTRITION; PROSTATE-SPECIFIC ANTIGEN; QUALITY OF LIFE; TESTOSTERONE;

EID: 61449151964     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.3945/ajcn.2008.26538     Document Type: Article

References (47)

1. Wurtman JJ, Lieberman H, Tsay R, Nader T, Chew B. Calorie and nutrient intakes of elderly and young subjects measured under identical conditions. J Gerontol 1988;43:B174-80.
2. Morley JE. Anorexia of aging: physiologic and pathologic. Am J Clin Nutr 1997;66:760-73.
3. Villareal DT, Apovian CM, Kushner RF, Klein S. Obesity in older adults: technical review and position statement of the American Society for Nutrition and NAASO, The Obesity Society. Am J Clin Nutr 2005; 82:923-34.
4. Wallace JI, Schwartz RS, LaCroix AZ, Uhlmann RF, Pearlman RA. Involuntary weight loss in older outpatients: incidence and clinical significance. J Am Geriatr Soc 1995;43:329-37.
5. Prentice AM, Jebb SA. Beyond body mass index. Obes Rev 2001;2: 141-7.
6. Doherty TJ. Invited review: aging and sarcopenia. J Appl Physiol 2003; 95:1717-27.
7. Melton LJ III, Khosla S, Riggs BL. Epidemiology of sarcopenia. Mayo Clin Proc 2000;75(suppl):S10-2 (discussion S12-3).
8. Janssen I, Baumgartner RN, Ross R, Rosenberg IH, Roubenoff R. Skeletal muscle cutpoints associated with elevated physical disability risk in older men and women. Am J Epidemiol 2004;159:413-21.
9. Baumgartner RN, Wayne SJ, Waters DL, Janssen I, Gallagher D, Morley JE. Sarcopenic obesity predicts instrumental activities of daily living disability in the elderly. Obes Res 2004;12:1995-2004.
10. Kamel HK. Sarcopenia and aging. Nutr Rev 2003;61:157-67.
11. Roubenoff R, Parise H, Payette HA, et al. Cytokines, insulin-like growth factor 1, sarcopenia, and mortality in very old community-dwelling men and women: the Framingham Heart Study. Am J Med 2003;115:429-35.
12. Chapman IM. Nutritional disorders in the elderly. Med Clin North Am 2006;90:887-907.
13. Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Heath CW Jr. Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med 1999;341:1097-105.
14. Newman AB, Yanez D, Harris T, Duxbury A, Enright PL, Fried LP. Weight change in old age and its association with mortality. J Am Geriatr Soc 2001;49:1309-18.
15. Visvanathan R, MacIntosh C, Callary M, Penhall R, Horowitz M, Chapman I. The nutritional status of 250 older Australian recipients of domiciliary care services and its association with outcomes at 12 months. J Am Geriatr Soc 2003;51:1007-11.
16. Milne AC, Potter J, Avenell A. Protein and energy supplementation in elderly people at risk from malnutrition. Cochrane Database Syst Rev 2005;CD003288.
17. Milne AC, Avenell A, Potter J. Meta-analysis: protein and energy supplementation in older people. Ann Intern Med 2006;144:37-48.
18. Amory JK, Chansky HA, Chansky KL, et al. Preoperative supra-physiological testosterone in older men undergoing knee replacement surgery. J Am Geriatr Soc 2002;50:1698-701.
19. Bakhshi V, Elliott M, Gentili A, Godschalk M, Mulligan T. Testosterone improves rehabilitation outcomes in ill older men. J Am Geriatr Soc 2000;48:550-3.
20. Page ST, Amory JK, Bowman FD, et al. Exogenous testosterone (T) alone or with finasteride increases physical performance, grip strength, and lean body mass in older men with low serum T. J Clin Endocrinol Metab 2005;90:1502-10.
21. Vellas B, Guigoz Y, Garry PJ, et al. The Mini Nutritional Assessment (MNA) and its use in grading the nutritional state of elderly patients. Nutrition 1999;15:116-22.
22. Folstein MF, Folstein SE, McHugh PR. ''Mini-mental state'': a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-98.
23. Yesavage JA, Brink TL, Rose TL, et al. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res 1982-1983;17:37-49.
24. Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001;56:M146-56.
25. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30:473-83.
26. Barry MJ, Fowler FJ Jr, O'Leary MP, et al. The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol 1992;148:1549-57 (discussion 1564).
27. Schofield DJ, Earnest A. Demographic change and the future demand for public hospital care in Australia, 2005 to 2050. Aust Health Rev 2006;30:507-15.
28. Hawai Health Information Corporation. Maui bed needs study 2005-2025. Honolulu, HI: Hawai Health Information Corporation, 2004.
29. Creditor MC. Hazards of hospitalization of the elderly. Ann Intern Med 1993;118:219-23.
30. Gill TM, Allore HG, Holford TR, Guo Z. Hospitalization, restricted activity, and the development of disability among older persons. JAMA 2004;292:2115-24.
31. Boyd CM, Xue QL, Guralnik JM, Fried LP. Hospitalization and development of dependence in activities of daily living in a cohort of disabled older women: the Women's Health and Aging Study I. J Gerontol A Biol Sci Med Sci 2005;60:888-93.
32. Wittert GA, Chapman IM, Haren MT, Mackintosh S, Coates P, Morley JE. Oral testosterone supplementation increases muscle and decreases fat mass in healthy elderly males with low-normal gonadal status. J Gerontol A Biol Sci Med Sci 2003;58:618-25.
33. Snyder PJ, Peachey H, Hannoush P, et al. Effect of testosterone treatment on body composition and muscle strength in men over 65 years of age. J Clin Endocrinol Metab 1999;84:2647-53.
34. Bhasin S, Woodhouse L, Casaburi R, et al. Older men are as responsive as young men to the anabolic effects of graded doses of testosterone on the skeletal muscle. J Clin Endocrinol Metab 2005;90:678-88.
35. Wierman ME, Basson R, Davis SR, et al. Androgen therapy in women: an Endocrine Society Clinical Practice guideline. J Clin Endocrinol Metab 2006;91:3697-710.
36. Davis SR, Tran J. Testosterone influences libido and well being in women. Trends Endocrinol Metab 2001;12:33-7.
37. Padero MC, Bhasin S, Friedman TC. Androgen supplementation in older women: too much hype, not enough data. J Am Geriatr Soc 2002;50: 1131-40.
38. Emmelot-Vonk MH, Verhaar HJ, Nakhai Pour HR, et al. Effect of testosterone supplementation on functional mobility, cognition, and other parameters in older men: a randomized controlled trial. JAMA 2008; 299:39-52.
39. Roubenoff R, Harris TB, Abad LW, Wilson PW, Dallal GE, Dinarello CA. Monocyte cytokine production in an elderly population: effect of age and inflammation. J Gerontol A Biol Sci Med Sci 1998;53: M20-6.
40. Yeh SS, Schuster MW. Geriatric cachexia: the role of cytokines. Am J Clin Nutr 1999;70:183-97.
41. Maggio M, Basaria S, Ble A, et al. Correlation between testosterone and the inflammatory marker soluble interleukin-6 receptor in older men. J Clin Endocrinol Metab 2006;91:345-7.
42. Nakhai-Pour HR, Grobbee DE, Emmelot-Vonk MH, Bots ML, Verhaar HJ, van der Schouw YT. Oral testosterone supplementation and chronic low-grade inflammation in elderly men: a 26-week randomized, placebo-controlled trial. Am Heart J 2007;154:1228.e1-7.
43. Kapoor D, Clarke S, Stanworth R, Channer KS, Jones TH. The effect of testosterone replacement therapy on adipocytokines and C-reactive protein in hypogonadal men with type 2 diabetes. Eur J Endocrinol 2007;156:595-602.
44. Due A, Toubro S, Stender S, Skov AR, Astrup A. The effect of diets high in protein or carbohydrate on inflammatory markers in overweight subjects. Diabetes Obes Metab 2005;7:223-9.
45. Harman SM, Metter EJ, Tobin JD, Pearson J, Blackman MR. Longitudinal effects of aging on serum total and free testosterone levels in healthy men: Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab 2001;86:724-31.
46. Kaskani E, Lyritis GP, Kosmidis C, et al. Effect of intermittent administration of 200 IU intranasal salmon calcitonin and low doses of 1alpha(OH) vitamin D3 on bone mineral density of the lumbar spine and hip region and biochemical bone markers in women with post-menopausal osteoporosis: a pilot study. Clin Rheumatol 2005;24:232-8.
47. Allan CA, Strauss BJ, Burger HG, Forbes EA, McLachlan RI. The association between obesity and the diagnosis of androgen deficiency in symptomatic ageing men. Med J Aust 2006;185:424-7.